16 results  1 of 1 

1 Comparison of Efficacy of Glimepiride, Alogliptin, and Alogliptin-Pioglitazone as the Initial Periods of Therapy in Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Multicenter, Randomized, Controlled Study
Hae Jin Kim, In Kyung Jeong, Kyu Yeon Hur, Soo-Kyung Kim, Jung Hyun Noh, Sung Wan Chun, Eun Seok Kang, Eun-Jung Rhee, Sung Hee Choi
Diabetes Metab J.2022;46(5):689-700.   Published online 2022 March 17     DOI: http://dx.doi.org/10.4093/dmj.2021.0183
      
2 Recent Perspective on Thiazolidinedione
Won Jun Kim
J Korean Diabetes.2021;22(2):97-104.   Published online 2021 June 30     DOI: http://dx.doi.org/10.4093/jkd.2021.22.2.97
      
3 Effect of Pioglitazone on Perihematomal Edema in Intracerebral Hemorrhage Mouse Model by Regulating NLRP3 Expression and Energy Metabolism
Hoon Kim, Jung Eun Lee, Hyun Ju Yoo, Jae Hoon Sung, Seung Ho Yang
J Korean Neurosurg Soc.2020;63(6):689-697.   Published online 2020 October 27     DOI: http://dx.doi.org/10.3340/jkns.2020.0056
      
4 Potential Therapeutic Strategy in Chronic Obstructive Pulmonary Disease Using Pioglitazone-Augmented Wharton's Jelly-Derived Mesenchymal Stem Cells
Jin-Soo Park, Hyun Kuk Kim, Eun-Young Kang, RyeonJin Cho, Yeon-Mok Oh
Tuberc Respir Dis.2019;82(2):158-165.   Published online 2018 September 28     DOI: http://dx.doi.org/10.4046/trd.2018.0044
      
5 Peroxisome proliferator-activated receptor gamma agonist as a novel treatment for interstitial cystitis: A rat model
Amandeep Mahal, Nichole Young-Lin, Amy Dobberfuhl, Jaclyn Estes, Craig Vance Comiter
Investig Clin Urol.2018;59(4):257-262.   Published online 2018 June 15     DOI: http://dx.doi.org/10.4111/icu.2018.59.4.257
      
6 Pioglitazone Attenuates Palmitate-Induced Inflammation and Endoplasmic Reticulum Stress in Pancreatic β-Cells
Seok-Woo Hong, Jinmi Lee, Jung Hwan Cho, Hyemi Kwon, Se Eun Park, Eun-Jung Rhee, Cheol-Young Park, Ki-Won Oh, Sung-Woo Park, Won-Young Lee
Endocrinol Metab.2018;33(1):105-113.   Published online 2018 March 21     DOI: http://dx.doi.org/10.3803/EnM.2018.33.1.105
      
7 Screening study for genetic polymorphisms affecting pharmacokinetics of pioglitazone
Ji Young Yun, Bo-Hyung Kim, Ji Hyun Lee, Kidong Lee, KyuBum Kwack, Sung-Vin Yim
Transl Clin Pharmacol.2016;24(4):194-202.   Published online 2016 January 19     DOI: http://dx.doi.org/10.12793/tcp.2016.24.4.194
   
8 Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database
Sunghwan Suh, Gi Hyeon Seo, Chang Hee Jung, Mee-Kyoung Kim, Sang-Man Jin, You-Cheol Hwang, Byung-Wan Lee, Jae Hyeon Kim
Diabetes Metab J.2015;39(3):247-252.   Published online 2015 April 22     DOI: http://dx.doi.org/10.4093/dmj.2015.39.3.247
      
9 Risk of Bladder Cancer among Patients with Diabetes Treated with a 15 mg Pioglitazone Dose in Korea: A Multi-Center Retrospective Cohort Study
Sang-Man Jin, Sun Ok Song, Chang Hee Jung, Jin-Sun Chang, Sunghwan Suh, Seung Min Kang, Inkyung Jung, Cheol-Young Park, Jae Hyeon Kim, Jae Hyoung Cho, Byung-Wan Lee
J Korean Med Sci.2014;29(2):238-242.   Published online 2014 January 28     DOI: http://dx.doi.org/10.3346/jkms.2014.29.2.238
      
10 Glycemic Effectiveness of Metformin-Based Dual-Combination Therapies with Sulphonylurea, Pioglitazone, or DPP4-Inhibitor in Drug-Naïve Korean Type 2 Diabetic Patients
Young Ki Lee, Sun Ok Song, Kwang Joon Kim, Yongin Cho, Younjeong Choi, Yujung Yun, Byung-Wan Lee, Eun-Seok Kang, Bong Soo Cha, Hyun Chul Lee
Diabetes Metab J.2013;37(6):465-474.   Published online 2013 December 12     DOI: http://dx.doi.org/10.4093/dmj.2013.37.6.465
      
11 Effects of a PPAR-γ (Peroxisome Proliferator-Activated Receptor-gamma) Activator on Flow-Mediated Brachial Artery Dilation and Circulating Level of microRNA-21 in Hypertensive Type 2 Diabetic Patients
Ji Weon Lee, Soon Jun Hong, Han Saem Jeong, Hyung Joon Joo, Jae Hyoung Park, Chul-Min Ahn, Cheol Woong Yu, Do-Sun Lim
J Korean Soc Hypertens.2013;19(4):99-111.   Published online 2013 December 10     DOI: http://dx.doi.org/10.5646/jksh.2013.19.4.99
   
12 Effects of Low Dose Pioglitazone on Restenosis and Coronary Atherosclerosis in Diabetic Patients Undergoing Drug Eluting Stent Implantation
Hye Won Lee, Han Cheol Lee, Bo Won Kim, Mi Jin Yang, Jin Sup Park, Jun Hyok Oh, Jung Hyun Choi, Kwang Soo Cha, Taek Jong Hong, Sang-Pil Kim, Seunghwan Song, Jong-Ha Park
Yonsei Med J.2013;54(6):1313-1320.   Published online 2013 October 1     DOI: http://dx.doi.org/10.3349/ymj.2013.54.6.1313
      
13 The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone
Sun Ok Song, Kwang Joon Kim, Byung-Wan Lee, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee
Diabetes Metab J.2012;36(5):371-378.   Published online 2012 October 18     DOI: http://dx.doi.org/10.4093/dmj.2012.36.5.371
      
14 The Effects of Pioglitazone in Reducing Atherosclerosis Progression and Neointima Volume in Type 2 Diabetic Patients: Prospective Randomized Study With Volumetric Intravascular Ultrasonography Analysis
Sung Hye You, Beum Suk Kim, Soon Jun Hong, Chul-Min Ahn, Do-Sun Lim
Korean Circ J.2010;40(12):625-631.   Published online 2010 December 31     DOI: http://dx.doi.org/10.4070/kcj.2010.40.12.625
      
15 Long-term Effect of Pioglitazone Treatment in Patients with Type 2 Diabetes
Jae Hoon Moon, Hye Jin Kim, Soo Kyung Kim, Wan Sub Shim, Eun Seuk Kang, Yumie Rhee, Chul Woo Ahn, Sung Kil Lim, Kyung Rae Kim, Hyun Chul Lee, Bong Soo Cha
J Korean Diabetes Assoc.2006;30(4):264-276.   Published online 2006 July 31     DOI: http://dx.doi.org/10.4093/jkda.2006.30.4.264
      
16 Effects of Pioglitazone on Cerebral Hemodynamics in Patients of Type 2 Diabetes
Jong Suk Park, You Jung Lee, Chul Sik Kim, Hai Jin Kim, Jina Park, Chul Woo Ahn, Kyung Yul Lee, Hyeong Jin Kim, Young Jun Won, Hun Ju Ha, Hae Sun Kwak, Bong Soo Cha, Sung Kil Lim, Kyung Rae Kim, Hyun Chul Lee
J Korean Diabetes Assoc.2006;30(2):96-103.   Published online 2006 March 31     DOI: http://dx.doi.org/10.4093/jkda.2006.30.2.96
      

 1 of 1